Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-4-28
pubmed:abstractText
It is well documented that cardiopulmonary bypass (CPB) severely impairs cellular immunity. The objective of this study was to investigate the effect of prostaglandin E1 (PGE1) on cellular immunity after CPB.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1344-4964
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-54
pubmed:meshHeading
pubmed-meshheading:16642920-Aged, pubmed-meshheading:16642920-Alprostadil, pubmed-meshheading:16642920-Cardiopulmonary Bypass, pubmed-meshheading:16642920-Cell Proliferation, pubmed-meshheading:16642920-Female, pubmed-meshheading:16642920-Glutathione, pubmed-meshheading:16642920-Heart Diseases, pubmed-meshheading:16642920-Humans, pubmed-meshheading:16642920-Immunity, Cellular, pubmed-meshheading:16642920-Leukocytes, Mononuclear, pubmed-meshheading:16642920-Male, pubmed-meshheading:16642920-Middle Aged, pubmed-meshheading:16642920-Oxidative Stress, pubmed-meshheading:16642920-Phytohemagglutinins, pubmed-meshheading:16642920-Platelet Aggregation Inhibitors, pubmed-meshheading:16642920-T-Lymphocytes, pubmed-meshheading:16642920-Time Factors, pubmed-meshheading:16642920-Treatment Outcome, pubmed-meshheading:16642920-Tuberculin, pubmed-meshheading:16642920-Vasodilator Agents
pubmed:year
2006
pubmed:articleTitle
Prostaglandin E1 attenuates impairment of cellular immunity after cardiopulmonary bypass.
pubmed:affiliation
Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
pubmed:publicationType
Journal Article, Randomized Controlled Trial